Back to discover

Protein / target

Somatostatin

Encoded bySSTP61278Homo sapiensSwiss-Prot
Small-molecule tractable
Druggability
Structure with Ligand
11
Research papers

Protein at a glance

Biological role

Hormone

Strongest disease association

Placental abruption

Via encoding gene SST · Genetic evidence · score 0.55

Research activity

Emerging research

11 papers · latest 2025

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Function overview

Inhibits the secretion of pituitary hormones, including that of growth hormone/somatotropin (GH1), PRL, ACTH, luteinizing hormone (LH) and TSH.

View complete UniProt function annotation

Inhibits the secretion of pituitary hormones, including that of growth hormone/somatotropin (GH1), PRL, ACTH, luteinizing hormone (LH) and TSH. Also impairs ghrelin- and GnRH-stimulated secretion of GH1 and LH; the inhibition of ghrelin-stimulated secretion of GH1 can be further increased by neuronostatin

Subcellular location

Secreted
Domains and Gene Ontology detail (23)

Gene Ontology

  • Ccytosol
  • Cextracellular region
  • Cextracellular space
  • CGABA-ergic synapse
  • Cneuronal cell body
  • Cneuronal dense core vesicle
  • Fhormone activity
  • Pcell surface receptor signaling pathway
  • Pcell-cell signaling
  • Pchemical synaptic transmission
  • Pdigestion
  • PG protein-coupled receptor signaling pathway

116 aa · 13 kDa

Biological roles

What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.

Synaptic signallingGOCell proliferation & survivalGOCell migrationGO
View supporting evidence

Synaptic signalling

  • ·GABA-ergic synapse
  • ·chemical synaptic transmission
  • ·regulation of postsynaptic membrane neurotransmitter receptor levels

Cell proliferation & survival

  • ·negative regulation of cell population proliferation

Cell migration

  • ·regulation of cell migration

Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.

Translational evidence

Open Targets 26

Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.

Strongest disease associations · via encoding gene SST

Gene-level evidence surfaced through the gene SSTthat encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.

Placental abruption
0.55Moderately supported

Genetic evidence dominant · Open Targets 0.33

Mouth Diseases
0.40Limited support

Genetic evidence dominant · Open Targets 0.25

Schizophrenia
0.30Limited support

Animal model evidence dominant · Open Targets 0.11

Pancreatitis
0.21Preliminary

Genetic evidence dominant · Open Targets 0.11

Osteoarthritis, Knee
0.18Preliminary

Genetic evidence dominant · Open Targets 0.11

View evidence synthesis (5)
Placental abruptionModerately supported
0.55
agreement 0.430.67
Genetic100%

Open Targets aggregate 0.33 · 1 independent evidence family

Mouth DiseasesLimited support
0.40
agreement 0.280.52
Genetic100%

Open Targets aggregate 0.25 · 1 independent evidence family

SchizophreniaLimited support
0.30
agreement 0.180.42
Animal model54%Literature35%Genetic11%

Open Targets aggregate 0.11 · 3 independent evidence families

PancreatitisPreliminary
0.21
agreement 0.070.35
Genetic80%Literature20%

Open Targets aggregate 0.11 · 2 independent evidence families

Osteoarthritis, KneePreliminary
0.18
agreement 0.040.32
Genetic95%Literature5%

Open Targets aggregate 0.11 · 2 independent evidence families

The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.

Show all associations
Placental abruption0.33
Mouth Diseases0.25
Alzheimer's Disease0.12
Pancreatitis0.11
Schizophrenia0.11
Osteoarthritis, Knee0.11

Tractability

Small moleculesEmerging

Feasibility evidence (structure with ligand) — no clinical-stage drug of this modality recorded.

AntibodiesEmerging

Feasibility evidence (go cc high conf and uniprot loc med conf) — no clinical-stage drug of this modality recorded.

Protein degradersEmerging

Feasibility evidence (half-life data) — no clinical-stage drug of this modality recorded.

View underlying tractability evidence (5)
SM · Structure with LigandAB · GO CC high confAB · UniProt loc med confAB · UniProt SigP or TMHMMPR · Half-life Data

Raw Open Targets tractability assessment buckets, by modality.

Research activity

11 papers · to 2025

Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.

Most cited

Caplin ME · The New England journal of medicine · 2014

Kawaguchi Y · Cerebral cortex (New York, N.Y. : 1991) · 1997

Gerhard DM · The Journal of clinical investigation · 2020

Dos Santos WO · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023

Recent

Cell-Type-Specific Effects of Somatostatin on Synaptic Transmission in the Anterior Cingulate Cortex.

Riedemann T · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2024

Synaptic and cellular endocannabinoid signaling mechanisms regulate stress-induced plasticity of nucleus accumbens somatostatin neurons.

Kondev V · Proceedings of the National Academy of Sciences of the United States of America · 2023

Synaptic plasticity at the dentate gyrus granule cell to somatostatin-expressing interneuron synapses supports object location memory.

Grigoryan G · Proceedings of the National Academy of Sciences of the United States of America · 2023

Growth Hormone Action in Somatostatin Neurons Regulates Anxiety and Fear Memory.

Dos Santos WO · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023

GABA interneurons are the cellular trigger for ketamine's rapid antidepressant actions.

Gerhard DM · The Journal of clinical investigation · 2020

Lanreotide in metastatic enteropancreatic neuroendocrine tumors.

Caplin ME · The New England journal of medicine · 2014

Europe PMC papers linked directly to this protein.